AUG 13, 2018 09:05 AM PDT

Silent Viruses Impact Microbe and Immune Cell Populations

Subclinical infection is an infection that is nearly or completely asymptomatic, they are prevalent in humans and result in lifelong persistence. Examples of subclinical infections include dengue virus, Neisseria gonorrhea, Staphylococcus aureus, Poliovirus, and measles virus among many others. Subclinical infections may alter the immune system and gut microbiota in the host, impacting how we respond to vaccines, pathogens, and environmental stimuli. A recent study published in the Journal of Virology sought to study the impact of subclinical viral infections on the interplay between the host immune response and gut microbiota.

CMV infected pneumocytes. Source: Dr. Yale Rosen

University of California Davis researchers utilized a member of the herpes family, cytomegalovirus, for this study. Cytomegalovirus is a common virus that infects 90% of adults in Africa and 70% in the United States and Europe, despite being ubiquitous it is generally not dangerous unless an individual’s immune system is compromised. While cytomegalovirus infections may be subclinical, it does not mean the virus is inactive in the human host. Researchers conducted the study in preclinical nonhuman primates that were free of subclinical viral infections or animals with subclinical viral infections through natural exposure to investigate the impact on immune cell distribution and function, as well as gut microbiota. Unlike previous studies environmental exposures were not limited, animals were housed in outdoor environments compared to controlled indoor settings.

Animals infected with cytomegalovirus had higher levels of Firmicutes and other butyrate-producing bacteria, butyrates are fatty acids that reduce inflammation and boost genes that help cytomegalovirus survive in the body. Regarding the immune response animals infected with cytomegalovirus showed a general increase in immune activity, specifically increased lymphocytes and cytokine-product T cells, but showed diminished antibodies responding to influenza vaccination. The data showed the subclinical cytomegalovirus infection heightens host immunity and gut microbiota changes in response to environmental stimuli. These changes may explain the heterogeneity in host immune response to vaccines and environment at the population level.

Dr. Satya Dandekar, the senior author on the paper, said "There's a high degree of variation at the population level of how people respond to vaccines, and all the factors that contribute to these variations are not fully understood. Our paper shows the subclinical CMV infections may be one of the issues that contribute to that immune variation. This opens a new opportunity to come up with novel approaches to optimize and position the immune system to have higher quality responses to vaccines". Future studies will focus on the effect cytomegalovirus subclinical infections may have on other vaccines as well as continuing to better understand how subclinical viruses affect the immune system in general.

To learn more about Cytomegalovirus watch the video below!

 

About the Author
  • Caitlin holds a doctorate degree in Microbiology from the University of Georgia where she studied Mycoplasma pneumoniae and its glycan receptors. She received her Bachelor's in Biology from Virginia Tech (GO HOKIES!). She has a passion for science communication and STEM education with a goal to improve science literacy. She enjoys topics related to human health, with a particular soft spot for pathogens.
You May Also Like
JUL 19, 2018
Microbiology
JUL 19, 2018
Mom's Microbiome has a Big Impact on Kid's Autism Risk
For many years, scientists have been trying to learn more about the causes of autism....
SEP 25, 2018
Immunology
SEP 25, 2018
A Better Place to Gain Weight
Weight gain among genders can have different outcomes....
OCT 29, 2018
Immunology
OCT 29, 2018
Escape of the Tumor Cell
Tumor cells in breast cancer have proven to evade the immune responses utilizing actin cytoskeleton...
OCT 31, 2018
Drug Discovery
OCT 31, 2018
New Drug Target For a Rare Lymphoma
The promise of immunotherapy in oncology is stronger than ever. Now, an international team of scientists and physicians from the Research Institute of the ...
NOV 07, 2018
Drug Discovery
NOV 07, 2018
Modifying Antibiotics For Drug Resistant Infections
In a study published in Nature Chemistry, researches at MIT were able to create a new chemical reaction that has the ability to modify antibiotics to make ...
NOV 13, 2018
Immunology
NOV 13, 2018
What Do Heart Disease and Autoimmune Diseases Have in Common?
Researchers at Washington University identify the link between autoimmune diseases and heart disease in mouse model...
Loading Comments...